Whalesbook Logo

Whalesbook

  • Home
  • About Us
  • Contact Us
  • News

Britannia Eyes Stronger H2 FY26 Growth Driven by GST Benefits and New Market Entry

Consumer Products

|

Updated on 07 Nov 2025, 05:53 pm

Whalesbook Logo

Reviewed By

Satyam Jha | Whalesbook News Team

Short Description:

Britannia Industries expects robust volume growth in the second half of FY26, following GST rate rationalization for food and beverage products from 12-18% to 5%. The company is increasing grammage on key low-unit packs and reducing prices on larger ones. Britannia also plans to enter the ready-to-drink protein beverage market and will enhance its regionalization strategy with new product launches and distribution expansion, aiming for high single-digit to double-digit volume growth.
Britannia Eyes Stronger H2 FY26 Growth Driven by GST Benefits and New Market Entry

▶

Stocks Mentioned:

Britannia Industries Limited

Detailed Coverage:

Britannia Industries anticipates a significant upturn in volume growth for the latter half of the current financial year (FY26). This optimism is largely fueled by the recent Goods and Services Tax (GST) rate rationalization, which has reduced the tax on most food and beverage products, including biscuits, from a range of 12-18% down to 5%. In response, Britannia has implemented strategic pricing and packaging adjustments. The company has increased the grammage (product weight) by 10-13% on its popular low-unit packs, such as Rs 5 and Rs 10 offerings, which constitute 65% of its portfolio. For larger packs, representing the remaining 35%, Britannia is enacting price reductions. These changes are expected to be fully rolled out by mid-November.

Impact: This news is highly positive for Britannia Industries and the broader Indian fast-moving consumer goods (FMCG) sector. The GST reduction and consequent price/grammage adjustments are designed to boost consumer demand and market share. The company's proactive strategies, including a strong focus on topline and volume-led growth, increased brand investment, and a revamped regionalization approach targeting smaller towns and rural areas, are expected to drive substantial growth. Entry into the ready-to-drink protein beverage market also opens new revenue streams. The company anticipates a shift from low single-digit or flat volume growth in the first half of FY26 to high single-digit or double-digit growth in the second half. Rating: 8/10

Difficult Terms: * **GST**: Goods and Services Tax. It is an indirect tax levied on the supply of goods and services. * **Volume Growth**: An increase in the quantity of goods or services sold by a company over a period. * **Grammage**: The weight of a product, especially in food items. Increasing grammage means providing more product for the same price or a lower price. * **Low-Unit Packs**: Smaller, typically less expensive product packaging sizes, often targeted at impulse purchases or lower-income consumers. * **Ready-to-Drink (RTD) Protein Beverage**: Beverages that are pre-packaged and ready for immediate consumption, specifically formulated to contain protein. * **Adjacencies**: Business areas or product categories that are closely related to a company's core business, offering opportunities for expansion. * **Unorganised Consumption**: Purchases made from informal sector businesses or vendors, as opposed to large retail chains or branded outlets. * **Organised Consumption**: Purchases made from formal retail chains, supermarkets, or branded stores.


Healthcare/Biotech Sector

Poly Medicure Reports 5% Rise in Q2 FY26 Net Profit, Driven by Domestic Growth and Strategic Acquisitions

Poly Medicure Reports 5% Rise in Q2 FY26 Net Profit, Driven by Domestic Growth and Strategic Acquisitions

India Mandates Stricter Pharma Manufacturing Standards by January Amidst Child Death Concerns

India Mandates Stricter Pharma Manufacturing Standards by January Amidst Child Death Concerns

SMS Pharmaceuticals Reports 76.4% Profit Jump on Strong Revenue Growth

SMS Pharmaceuticals Reports 76.4% Profit Jump on Strong Revenue Growth

Poly Medicure Reports 5% Rise in Q2 FY26 Net Profit, Driven by Domestic Growth and Strategic Acquisitions

Poly Medicure Reports 5% Rise in Q2 FY26 Net Profit, Driven by Domestic Growth and Strategic Acquisitions

India Mandates Stricter Pharma Manufacturing Standards by January Amidst Child Death Concerns

India Mandates Stricter Pharma Manufacturing Standards by January Amidst Child Death Concerns

SMS Pharmaceuticals Reports 76.4% Profit Jump on Strong Revenue Growth

SMS Pharmaceuticals Reports 76.4% Profit Jump on Strong Revenue Growth


Brokerage Reports Sector

Brokerages Issue Fresh Recommendations on Top Stocks Across Sectors

Brokerages Issue Fresh Recommendations on Top Stocks Across Sectors

Brokerages Issue Fresh Recommendations on Top Stocks Across Sectors

Brokerages Issue Fresh Recommendations on Top Stocks Across Sectors